Drug Profile
Todoxin
Latest Information Update: 26 Aug 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antivirals
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 14 Oct 1998 Profile reviewed
- 16 May 1995 Phase-III clinical trials for HIV infections treatment (PO)
- 15 May 1995 New profile